STOCK TITAN
  1. Home
  2. Sec-filings
  3. PAVM
  4. [Form 4] PAVmed Inc. Insider Trading Activity

Restricted stock award boosts PAVmed (NASDAQ: PAVM) director stake

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Agrawal Sundeep reported acquisition or exercise transactions in this Form 4 filing.

PAVmed Inc. director Sundeep Agrawal received a grant of 13,930 shares of restricted Common Stock as equity compensation. The award was granted at no cash purchase price and increases his direct holdings to 19,337 shares after the transaction.

The restricted stock was issued under PAVmed’s Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan and has a single vesting date of May 20, 2029. The shares are subject to forfeiture if he does not complete the required service period, tying the award to long-term board service.

Positive

  • None.

Negative

  • None.
Insider Agrawal Sundeep
Role Director
Type Security Shares Price Value
Grant/Award Common Stock 13,930 $0.00 --
Holdings After Transaction: Common Stock — 19,337 shares (Direct)
Footnotes (1)
  1. [object Object]
Restricted stock granted 13,930 shares Equity award to director Sundeep Agrawal
Holdings after transaction 19,337 shares Director’s direct Common Stock ownership after grant
Grant price $0.0000 per share Compensation grant, not open-market purchase
Vesting date May 20, 2029 Single vesting date for restricted stock award
restricted stock financial
"Represents restricted stock granted to the reporting person under the issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
vesting date financial
"with a single vesting date of May 20, 2029"
subject to forfeiture financial
"Such restricted stock is subject to forfeiture if the requisite service period is not completed"
Long-Term Incentive Equity Plan financial
"under the issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan"
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Agrawal Sundeep
(Last)(First)(Middle)
360 MADISON AVENUE, 25TH FLOOR
(Street)
NEW YORK NEW YORK 10017
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
PAVmed Inc. [ PAVM ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/02/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/02/2026A13,930(1)A$0(1)19,337D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents restricted stock granted to the reporting person under the issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed.
/s/ Michael A. Gordon, by power of attorney04/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did PAVmed (PAVM) disclose about director Sundeep Agrawal’s Form 4 transaction?

PAVmed reported that director Sundeep Agrawal received a grant of 13,930 shares of restricted Common Stock. The award was issued at no cash price as equity compensation and increased his direct holdings to 19,337 shares after the transaction.

Is the PAVmed (PAVM) Form 4 transaction an open-market stock purchase or sale?

The filing shows a grant of restricted stock, not an open-market trade. Code “A” reflects a grant or award acquisition, issued at a price of $0.0000 per share as part of compensation, rather than a voluntary buy or sell on the open market.

How many PAVmed (PAVM) shares does Sundeep Agrawal hold after this grant?

After receiving 13,930 restricted shares, Sundeep Agrawal directly holds a total of 19,337 shares of PAVmed Common Stock. This total includes the newly granted restricted stock subject to vesting and forfeiture conditions tied to his service.

When do Sundeep Agrawal’s newly granted PAVmed (PAVM) restricted shares vest?

The restricted stock granted to Sundeep Agrawal has a single vesting date of May 20, 2029. Vesting requires completion of a specified service period; if that service condition is not met, the unvested restricted shares may be forfeited.

What conditions apply to the new PAVmed (PAVM) restricted stock grant?

The 13,930 restricted shares are subject to forfeiture if the requisite service period is not completed. They were granted under PAVmed’s Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan, aligning director compensation with long-term company service.